Type II phosphoinositide 5‐phosphatases have unique sensitivities towards fatty acid composition and head group phosphorylation
- 11 September 2004
- journal article
- research article
- Published by Wiley in FEBS Letters
- Vol. 576 (1-2), 9-13
- https://doi.org/10.1016/j.febslet.2004.08.052
Abstract
The catalytic properties of the type II phosphoinositide 5-phosphatases of Lowe's oculocerebrorenal syndrome, INPP5B, Synaptojanin1, Synaptojanin2 and SKIP were analysed with respect to their substrate specificity and enzymological properties. Our data reveal that all phosphatases have unique substrate specificities as judged by their corresponding KM and VMax values. They also possessed an exclusive sensitivity towards fatty acid composition, head group phosphorylation and micellar presentation. Thus, the biological function of these enzymes will not just be determined by their corresponding regulatory domains, but will be distinctly influenced by their catalytic properties as well. This suggests that the phosphatase domains fulfil a unique catalytic function that cannot be fully compensated by other phosphatases.Keywords
This publication has 23 references indexed in Scilit:
- Lowe syndrome protein OCRL1 interacts with Rac GTPase in the trans-Golgi networkHuman Molecular Genetics, 2003
- Identification of a Novel Domain in Two Mammalian Inositol-polyphosphate 5-Phosphatases That Mediates Membrane Ruffle LocalizationPublished by Elsevier ,2003
- The Structure and Function of Catalytic Domains Within Inositol Polyphosphate 5‐PhosphatasesIUBMB Life, 2002
- Synthesis and Function of 3-Phosphorylated Inositol LipidsAnnual Review of Biochemistry, 2001
- Identification and Characterization of a Novel Inositol Polyphosphate 5-PhosphatasePublished by Elsevier ,2000
- Ocrl1, a PtdIns(4,5)P25-Phosphatase, Is Localized to theTrans-Golgi Network of Fibroblasts and Epithelial CellsJournal of Histochemistry & Cytochemistry, 2000
- Functional overlap between murine Inpp5b and Ocrl1 may explain why deficiency of the murine ortholog for OCRL1 does not cause Lowe syndrome in mice.Journal of Clinical Investigation, 1998
- Synaptojanin 2, a Novel Synaptojanin Isoform with a Distinct Targeting Domain and Expression PatternPublished by Elsevier ,1997
- Inositol lipid 5-phosphatases-traffic signals and signal trafficTrends in Biochemical Sciences, 1997
- The Lowe's oculocerebrorenal syndrome gene encodes a protein highly homologous to inositol polyphosphate-5-phosphataseNature, 1992